Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001262463-13-000363
Filing Date
2013-06-06
Accepted
2013-06-06 12:21:57
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A plpl123110qa.htm 10-Q/A 357358
2 EXHIBIT 31.1 ex311.htm EX-31 8906
3 EXHIBIT 31.2 ex312.htm EX-31 8848
4 EXHIBIT 32.1 ex321.htm EX-32 4860
5 EXHIBIT 32.2 ex322.htm EX-32 4746
  Complete submission text file 0001262463-13-000363.txt   2682823

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE plpl-20121231.xml EX-101.INS 335566
7 XBRL SCHEMA FILE plpl-20121231.xsd EX-101.SCH 26495
8 XBRL CALCULATION FILE plpl-20121231_cal.xml EX-101.CAL 36116
9 XBRL DEFINITION FILE plpl-20121231_def.xml EX-101.DEF 74655
10 XBRL LABEL FILE plpl-20121231_lab.xml EX-101.LAB 140885
11 XBRL PRESENTATION FILE plpl-20121231_pre.xml EX-101.PRE 139657
Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102
Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 (425) 466-0212
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

EIN.: 453642179 | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 000-51206 | Film No.: 13896521
SIC: 2834 Pharmaceutical Preparations